【NEWS】Cyto-Facto Inc. has raised 1.18 billion Yen through third-Party allocation shares as Series A.


Cyto-Facto has raised a total of 1.18 billion Yen through the third-party allocation of shares as Series A Fund-raising with investments from MPower Partners and D3 LLC as lead investors respectively, and many business corporations and VCs including Asahi Kasei, Mitsubishi Corporation, Kobe University Capital, Mizuho Capital, SMBC Venture Capital, and others as follower investors.

Please check a link for detailed information.

April. 22. 2024
Cyto-Facto Inc.